Chang / Ganz / Hayes Oncology

An Evidence-Based Approach
1. Auflage 2007
ISBN: 978-0-387-31056-5
Verlag: Springer US
Format: PDF
Kopierschutz: 1 - PDF Watermark

E-Book, Englisch, 2012 Seiten

Title consistently uses the evidence-based approach Evidence-based tables make documentation of care plan easy Interdisciplinary orientation - all aspects of patient care are covered Only book that involves experts from the entire range of cancer treatment in the fields of medical, surgical and radiation oncology Includes hot topics such as prevention and breast cancer Offers ground-breaking sections on the latest research and clinical applications in cancer survivorship Chapter on PET addresses imaging issues and how to get the best results Most comprehensive sections on the biology and epidemiology of cancer as compared to competitors

Autoren/Hrsg.

Chang, Alfred E.

Ganz, Patricia A.

Hayes, Daniel F.

Kinsella, Timothy

Pass, Harvey I.

Schiller, Joan H.

Stone, Richard M.

Strecher, Victor

Inhaltsverzeichnis

1;Foreword;6
2;Preface;11
3;Contents;13
4;Contributors;21
5;Principles of Oncology;40
5.1;Evidence-Based Approach to Oncology;41
5.2;Principles of Chemotherapy;52
5.3;Principles of Radiation Oncology;79
5.4;Principles of Surgical Therapy in Oncology;96
5.5;Principles of Targeted and Biological Therapies;111
5.6;Biologic Principles of Hematopoietic Stem Cell Transplantation;129
5.7;Evaluation of Tumor Markers: An Evidence- Based Guide for Determination of Clinical Utility;144
5.8;Design and Analysis of Oncology Clinical Trials;150
5.9;Ethics of Clinical Oncology Research;165
5.10;Informatics Infrastructure for Evidence- Based Cancer Medicine;181
5.11;Economics of Cancer Care;189
5.12;Principles of Screening for Cancer;199
5.13;Patient Decision Making;215
5.14;Establishing an Interdisciplinary Oncology Team;222
5.15;Principles of Complementary and Alternative Medicine for Cancer;232
6;Translational Basic Science;242
6.1;Fundamental Aspects of the Cell Cycle and Signal Transduction;243
6.2;Viral Carcinogenesis;250
6.3;Environmental Carcinogenesis;269
6.4;Cancer Metastasis;280
6.5;Tumor Immunology and Immunotherapy;290
6.6;Technologies in Molecular Biology: Diagnostic Applications;305
7;Cancer Prevention and Control;321
7.1;Cancer Epidemiology;322
7.2;Evidence-Based Cancer Prevention Research: A Multidisciplinary Perspective on Cancer Prevention Trials;336
7.3;Screening;352
7.4;Genetic Screening and Counseling for High- Risk Populations;376
7.5;Behavior Modification;393
8;Cancer Imaging;402
8.1;Central Nervous System Imaging;403
8.2;Breast Imaging;415
8.3;Imaging of Thoracic Malignancies;426
8.4;Imaging of Gastrointestinal Stromal Tumor;447
8.5;Genitourinary Imaging;459
8.6;Musculoskeletal Imaging;476
8.7;Positron Emission Tomography and Cancer;483
9;Solid Tumors;518
9.1;Central Nervous System Tumors;519
9.2;Eye, Orbit, and Adnexal Structures;538
9.3;Head and Neck Cancer;566
9.4;Lung Cancer;583
9.5;Therapy for Malignant Pleural Mesothelioma;660
9.6;Mediastinum;683
9.7;Esophageal Cancer;702
9.8;Stomach;718
9.9;Colon, Rectal, and Anal Cancer Management;742
9.10;Adenocarcinoma and Other Small Intestinal Malignancies;771
9.11;Cancer of the Liver and Bile Ducts;783
9.12;An Evidence-Based Approach to the Management of Pancreatic Cancer;802
9.13;Renal Cell Cancer;820
9.14;Ureter, Bladder, Penis, and Urethra;844
9.15;Prostate Cancer;864
9.16;Testis Cancer;882
9.17;Cervix, Vulva, and Vagina;912
9.18;Gestational Trophoblastic Neoplasia;930
9.19;Ovarian Cancer;941
9.20;Uterine Malignancies;968
9.21;Evidence-Based Management of Breast Cancer;991
9.22;Thyroid and Parathyroid;1023
9.23;Tumors of the Endocrine System;1045
9.24;Sarcomas of Bone;1065
9.25;Soft Tissue Sarcoma;1079
9.26;Cutaneous Melanoma;1113
9.27;Nonmelanoma Cutaneous Malignancies;1133
9.28;Cancer of Unknown Primary Site;1150
9.29;Solid Tumors of Childhood;1164
10;Hematologic Malignancies;1188
10.1;Acute Myeloid Leukemia and the Myelodysplastic Syndromes;1189
10.2;Acute Lymphoblastic Leukemia;1211
10.3;Chronic Lymphocytic Leukemia and Related Chronic Leukemias;1239
10.4;Chronic Myeloid Leukemia;1258
10.5;An Evidence-Based Approach to the Management of Hodgkin’s Lymphoma;1269
10.6;The Non-Hodgkin’s Lymphomas;1285
10.7;Multiple Myeloma;1314
11;Practice of Oncology;1326
11.1;Superior Vena Cava Syndrome;1327
11.2;Central Nervous System Emergencies;1335
11.3;Metabolic Emergencies in Oncology;1348
11.4;Surgical Emergencies;1359
11.5;Oral Complications of Cancer Therapy;1376
11.6;Alopecia and Cutaneous Complications of Chemotherapy;1390
11.7;Infectious Complications of Cancer Therapy;1399
11.8;Acute Toxicities of Therapy: Pulmonary Complications;1437
11.9;Cardiac Complications;1447
11.10;Neurologic Complications of Therapy;1454
11.11;Acute Toxicities of Therapy: Urologic Complications;1462
11.12;Issues in Vascular Access with Special Emphasis on the Cancer Patient;1470
11.13;Management of Cancer Pain;1482
11.14;Nausea and Vomiting in the Cancer Patient;1509
11.15;Nutritional Support for the Cancer Patient;1524
11.16;Paraneoplastic Syndromes;1542
11.17;Malignant Effusions;1554
11.18;Evidence-Based Use of Hematopoietic Growth Factors for Optimal Supportive Care of Patients with Cancer;1562
11.19;Management of the Bone Marrow Transplant Patient;1572
11.20;Management of Anxiety and Depression in Adult Cancer Patients: Toward an Evidence- Based Approach;1588
11.21;Reproductive Complications and Sexual Dysfunction in the Cancer Patient;1616
11.22;The Care of the Terminal Patient;1637
11.23;Metastatic Cancer to the Central Nervous System;1648
11.24;Metastatic Cancer to Lung;1662
11.25;Surgical and Regional Therapy for Liver Metastases;1672
11.26;Metastatic Cancer to Bone;1691
11.27;Cancer in the Immunosuppressed Patient;1716
11.28;Cancer in the Older Population;1744
11.29;Chemotherapy in Patients with Organ Dysfunction;1757
11.30;Management of the Pregnant Cancer Patient;1774
12;Cancer Survivorship;1787
12.1;Survivorship Research: Past, Present, and Future;1788
12.2;Late Effects of Cancer Treatments;1803
12.3;Medical and Psychosocial Issues in Childhood Cancer Survivors;1826
12.4;Medical and Psychosocial Issues in Hodgkin’s Disease Survivors;1839
12.5;Medical and Psychosocial Issues in Testicular Cancer Survivors;1850
12.6;Medical and Psychosocial Issues in Gynecologic Cancer Survivors;1863
12.7;Medical, Psychosocial, and Health- Related Quality of Life Issues in Breast Cancer Survivors;1871
12.8;Medical and Psychosocial Issues in Prostate Cancer Survivors;1894
12.9;Physical and Psychosocial Issues in Lung Cancer Survivors;1906
12.10;Cancer Survivorship Issues in Colorectal Cancer;1926
12.11;Medical and Psychosocial Issues in Transplant Survivors;1937
12.12;Second Malignancies After Radiation Treatment and Chemotherapy for Primary Cancers;1964
12.13;Psychosocial Rehabilitation in Cancer Care;1977
12.14;Cancer Advocacy;1990
13;Index;1994